Cluster-randomised trial evaluating a complex intervention to improve mental health and well-being of employees working in hospital - a protocol for the SEEGEN trial.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
17 Dec 2019
Historique:
received: 11 10 2019
accepted: 07 11 2019
entrez: 19 12 2019
pubmed: 19 12 2019
medline: 5 3 2020
Statut: epublish

Résumé

Health care employees in Germany and worldwide are exposed to a variety of stressors. However, most of the hospitals in Germany lack a systematic workplace health management. Thus, this study aims at the evaluation of the effects of a behavioural as well as organisational (´complex´) intervention on the mental health and well-being of hospital staff. Mental health in the hospital workplace (SEElische GEsundheit am Arbeitsplatz KrankeNhaus - SEEGEN) is an unblinded, multi-centred cluster-randomised open trial with two groups (intervention group (IG) and waitlist control group (CG)). Study participants in the intervention clusters will receive the complex intervention; study participants in the waitlist control clusters will receive the complex intervention after the last follow-up measurement. The intervention consists of five behavioural and organisational intervention modules that are specifically tailored to hospital employees at different hierarchical and functional levels. Hospital staff may select one specific module according to their position and specific needs or interests. Towards the end of the intervention roundtable discussions with representatives from all professional groups will be held to facilitate organisational change. Primary outcome is the change in emotional and cognitive strain in the working environment, from baseline (T0) to 6 month-follow up (T1), between IG and CG. In addition, employees who do not participate in the modules are included in the trial by answering shorter questionnaires (cluster participants). Furthermore, using mixed methods, a process evaluation will identify uptake of the intervention, and mediators and moderators of the effect. There seems to be growing psychological strain on people working in the health care sector worldwide. This study will examine whether investing directly in the hospital staff and their interpersonal relationship may lead to measurable benefits in subjective well-being at the workplace and improved economic performance indicators of the hospital. In case of a positive outcome, health promotion strategies looking at behavioural as well as organisational components within the hospital may gain additional importance, especially in regard of the growing financial pressure within the health sector. The SEEGEN study is registered at the German Clinical Trial Register (DRKS) under the DRKS-ID DRKS00017249. Registered 08 October 2019, URL. https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00017249.

Sections du résumé

BACKGROUND BACKGROUND
Health care employees in Germany and worldwide are exposed to a variety of stressors. However, most of the hospitals in Germany lack a systematic workplace health management. Thus, this study aims at the evaluation of the effects of a behavioural as well as organisational (´complex´) intervention on the mental health and well-being of hospital staff.
METHODS METHODS
Mental health in the hospital workplace (SEElische GEsundheit am Arbeitsplatz KrankeNhaus - SEEGEN) is an unblinded, multi-centred cluster-randomised open trial with two groups (intervention group (IG) and waitlist control group (CG)). Study participants in the intervention clusters will receive the complex intervention; study participants in the waitlist control clusters will receive the complex intervention after the last follow-up measurement. The intervention consists of five behavioural and organisational intervention modules that are specifically tailored to hospital employees at different hierarchical and functional levels. Hospital staff may select one specific module according to their position and specific needs or interests. Towards the end of the intervention roundtable discussions with representatives from all professional groups will be held to facilitate organisational change. Primary outcome is the change in emotional and cognitive strain in the working environment, from baseline (T0) to 6 month-follow up (T1), between IG and CG. In addition, employees who do not participate in the modules are included in the trial by answering shorter questionnaires (cluster participants). Furthermore, using mixed methods, a process evaluation will identify uptake of the intervention, and mediators and moderators of the effect.
DISCUSSION CONCLUSIONS
There seems to be growing psychological strain on people working in the health care sector worldwide. This study will examine whether investing directly in the hospital staff and their interpersonal relationship may lead to measurable benefits in subjective well-being at the workplace and improved economic performance indicators of the hospital. In case of a positive outcome, health promotion strategies looking at behavioural as well as organisational components within the hospital may gain additional importance, especially in regard of the growing financial pressure within the health sector.
TRIAL REGISTRATION DRKS UNASSIGNED
The SEEGEN study is registered at the German Clinical Trial Register (DRKS) under the DRKS-ID DRKS00017249. Registered 08 October 2019, URL. https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00017249.

Identifiants

pubmed: 31847898
doi: 10.1186/s12889-019-7909-4
pii: 10.1186/s12889-019-7909-4
pmc: PMC6918673
doi:

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

1694

Investigateurs

Anja Greinacher (A)
Kirsten Bikowski (K)
Marieke Born (M)
Antonia Drews (A)
Lina Hermeling (L)
Bernd Puschner (B)
Elena Tsarouha (E)
Lucia Jerg-Bretzke (L)
Meinhard Kieser (M)

Références

Psychother Psychosom Med Psychol. 2017 Apr;67(3-04):161-173
pubmed: 28403499
Psychother Psychosom. 2015;84(3):167-76
pubmed: 25831962
Int Arch Occup Environ Health. 2012 Jan;85(1):67-79
pubmed: 21584721
Cochrane Database Syst Rev. 2010 Mar 17;(3):CD003541
pubmed: 20238322
Harv Bus Rev. 2003 Dec;81(12):46-54, 124
pubmed: 14712543
Stat Methods Med Res. 2007 Jun;16(3):219-42
pubmed: 17621469
Psychol Med. 2007 Aug;37(8):1131-40
pubmed: 17445281
J Ment Health Adm. 1991 Summer;18(2):148-53
pubmed: 10112337
Psychooncology. 2018 May;27(5):1426-1433
pubmed: 29314432
PLoS One. 2018 Jan 19;13(1):e0191000
pubmed: 29351310
Ann Epidemiol. 2004 Jan;14(1):24-30
pubmed: 14664776
Lancet. 2019 Jul 13;394(10193):93
pubmed: 31305255
Cochrane Database Syst Rev. 2015 Apr 07;(4):CD002892
pubmed: 25847433
Front Psychiatry. 2019 Sep 03;10:622
pubmed: 31551829
Crit Care Nurse. 2017 Oct;37(5):e1-e9
pubmed: 28966203
Scand J Work Environ Health. 2017 Jul 1;43(4):294-306
pubmed: 28306759
Ann Intern Med. 2013 Feb 5;158(3):200-7
pubmed: 23295957
BMC Public Health. 2015 Aug 01;15:738
pubmed: 26232123
Neurosci Biobehav Rev. 2013 Sep;37(8):1810-23
pubmed: 23891906
Occup Environ Med. 2007 Oct;64(10):659-65
pubmed: 17259167
Int Arch Occup Environ Health. 2009 Aug;82(8):1005-13
pubmed: 19018554
JAMA Surg. 2018 May 1;153(5):403-404
pubmed: 29516082

Auteurs

Nadine Mulfinger (N)

Clinic of Psychosomatic Medicine and Psychotherapy, University Hospital Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany.

Anja Sander (A)

Institute of Medical Biometry and Informatics, University of Heidelberg, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany.

Felicitas Stuber (F)

Department of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen Osianderstraße 5, 72076, Tübingen, Germany.

Regina Brinster (R)

Institute of Medical Biometry and Informatics, University of Heidelberg, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany.

Florian Junne (F)

Department of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen Osianderstraße 5, 72076, Tübingen, Germany.

Ronald Limprecht (R)

Institute of Medical Biometry and Informatics, University of Heidelberg, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany.

Marc N Jarczok (MN)

Clinic of Psychosomatic Medicine and Psychotherapy, University Hospital Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany.

Tanja Seifried-Dübon (T)

Department of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen Osianderstraße 5, 72076, Tübingen, Germany.

Monika A Rieger (MA)

Institute for Occupational and Social Medicine and Health Services Research, University Hospital Tübingen, Wilhelmstraße 27, 72074, Tübingen, Germany.

Stephan Zipfel (S)

Department of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen Osianderstraße 5, 72076, Tübingen, Germany.

Martin Peters (M)

Department of Psychiatry II, Ulm University and Bezirkskrankenhaus Günzburg, Ludwig-Heilmeyer-Str. 2, 89312, Günzburg, Germany.

Maja Stiawa (M)

Department of Psychiatry II, Ulm University and Bezirkskrankenhaus Günzburg, Ludwig-Heilmeyer-Str. 2, 89312, Günzburg, Germany.

Imad Maatouk (I)

Department for General Internal Medicine and Psychosomatics, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.

Madeleine Helaß (M)

Department for General Internal Medicine and Psychosomatics, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.

Christoph Nikendei (C)

Department for General Internal Medicine and Psychosomatics, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.

Eva Rothermund (E)

Clinic of Psychosomatic Medicine and Psychotherapy, University Hospital Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany.

Nicole Hander (N)

Clinic of Psychosomatic Medicine and Psychotherapy, University Hospital Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany.

Ute Ziegenhain (U)

Clinic of Child- and Adolescents Psychiatry / Psychotherapy, University Hospital Ulm, Steinhövelstraße 3, 89075, Ulm, Germany.

Manuela Gulde (M)

Clinic of Child- and Adolescents Psychiatry / Psychotherapy, University Hospital Ulm, Steinhövelstraße 3, 89075, Ulm, Germany.

Melanie Genrich (M)

Institute of Psychology, Work and Organisational Psychology, University of Duisburg-Essen, Universitätsstr. 2, 45141, Essen, Germany.

Britta Worringer (B)

Institute of Occupational and Social Medicine, Heinrich-Heine-University Düsseldorf, Universitätsstraße 1, 40225, Düsseldorf, Germany.

Janna Küllenberg (J)

Institute for Medical Psychology, University Hospital Heidelberg, Bergheimer Straße 20, 69115, Heidelberg, Germany.

Karl Blum (K)

German Hospital Institute (DKI) e.V, Hansaallee 201, Haus 1, 40549, Düsseldorf, Germany.

Stefan Süß (S)

Chair of Business Administration, in particular Work, Human Resource Management and Organisation Studies, Heinrich-Heine-University Düsseldorf, Universitätsstraße 1, 40225, Düsseldorf, Germany.

Elena Gesang (E)

Chair of Business Administration, in particular Work, Human Resource Management and Organisation Studies, Heinrich-Heine-University Düsseldorf, Universitätsstraße 1, 40225, Düsseldorf, Germany.

Sascha Ruhle (S)

Chair of Business Administration, in particular Work, Human Resource Management and Organisation Studies, Heinrich-Heine-University Düsseldorf, Universitätsstraße 1, 40225, Düsseldorf, Germany.

Andreas Müller (A)

Institute of Psychology, Work and Organisational Psychology, University of Duisburg-Essen, Universitätsstr. 2, 45141, Essen, Germany.

Jochen Schweitzer-Rothers (J)

Institute for Medical Psychology, University Hospital Heidelberg, Bergheimer Straße 20, 69115, Heidelberg, Germany.

Peter Angerer (P)

Institute of Occupational and Social Medicine, Heinrich-Heine-University Düsseldorf, Universitätsstraße 1, 40225, Düsseldorf, Germany.

Harald Gündel (H)

Clinic of Psychosomatic Medicine and Psychotherapy, University Hospital Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany. harald.guendel@uniklinik-ulm.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH